Skip to main content
. 2020 Sep 2;21(17):6391. doi: 10.3390/ijms21176391

Figure 2.

Figure 2

Figure 2

Effect of knockdown PROK2 on cell viability and cell cycle in human cervical cancer HeLa cells. (A,B) Immunoblotting and RT-qPCR analysis of PROK2 protein and mRNA expression in three cervical cancer cell lines (C33A, HeLa and SiHa). β-actin as a protein loading control, GAPDH as a mRNA loading control. (C,D) The protein and mRNA expression of PROK2 in shLuc- or shPROK2-HeLa cells. (E) Cell viability of shLuc- or shPROK2-HeLa cells was measured by cell viability assay at 24 h and 48 h after seeding. (F) Cell cycle distribution of shLuc- or shPROK2-HeLa cells were measured by flow cytometry.